Contents
Exploring the Latest Research on Hyperparathyroidism
Published: Jul 31, 2024
Ongoing research provides new insights into hyperparathyroidism and its management. Dive into the latest studies and findings.
Global Trends in PHPT
Research shows that the prevalence of PHPT is rising globally, with significant variations between regions. Studies from India and China highlight a higher incidence of symptomatic cases, possibly due to dietary and environmental factors. Understanding these trends can guide healthcare strategies and improve patient outcomes worldwide.
Normocalcemic PHPT: A New Focus
Normocalcemic PHPT, where calcium levels are normal but parathyroid hormone levels are elevated, is gaining attention. Recent studies suggest this condition may precede traditional PHPT, highlighting the need for early detection. Researchers are exploring its progression and potential impact on bone density and kidney health.
Advancements in Treatment
New treatments and surgical techniques are being developed to manage PHPT more effectively. Minimally invasive procedures and targeted therapies show promise in reducing complications and improving recovery. Ongoing trials aim to refine these approaches and provide better options for patients.
Frequently Asked Questions
Yes, global studies indicate a rising prevalence.
It's a form of PHPT with normal calcium but high hormone levels.
Yes, research is developing new surgical and therapy options.
Early detection can prevent complications and improve outcomes.
The Future of PHPT
Continued research is key to advancing the understanding and management of hyperparathyroidism.
References
- Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: a tale of two cities--New York and Beijing. Int J Fertil Womens Med 2000; 45:158.
- Assadipour Y, Zhou H, Kuo EJ, et al. End-organ effects of primary hyperparathyroidism: A population-based study. Surgery 2019; 165:99.
- Cusano NE, Maalouf NM, Wang PY, et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 2013; 98:2734.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?